Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 12Recruiting 4Unknown 2Terminated 2Not yet recruiting 2Active not recruiting 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 1841Neoplasms 1230Colorectal Neoplasms 1046Carcinoma, Non-Small-Cell Lung 996Stomach Neoplasms 787Carcinoma, Hepatocellular 780Lung Neoplasms 756Prostatic Neoplasms 682Pancreatic Neoplasms 567Rectal Neoplasms 444Colonic Neoplasms 401Neoplasm Metastasis 400Ovarian Neoplasms 399Uterine Cervical Neoplasms 395Recurrence 380Leukemia, Myeloid, Acute 367Esophageal Neoplasms 352Multiple Myeloma 340Lymphoma 330Head and Neck Neoplasms 326Melanoma 306Precursor Cell Lymphoblastic Leukemia-Lymphoma 288Brain Neoplasms 263Urinary Bladder Neoplasms 249Nasopharyngeal Carcinoma 221Liver Neoplasms 221Leukemia 217Lymphoma, Large B-Cell, Diffuse 213Polycystic Ovary Syndrome 206Squamous Cell Carcinoma of Head and Neck 200

Interventions

Drug Therapy 1Cognitive Training 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Cognition Disorders × Clear all
NCT02753036 2021-08-19

CICARO

Charite University, Berlin, Germany

Unknown
72 enrolled

Chemotherapy-Related Cognitive Impairment, Cognition Disorders, Neoplasms, Polyneuropathies

NCT00256425 2008-03-21

Cognitive Rehabilitation of Glioma Patients

UMC Utrecht

Phase 3 Unknown
140 enrolled
CNS

Brain Neoplasms, Cognition Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡